Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The antileprosy agent B.663 (Clofazimine) and the reticuloendothelial system.

× No keyword cloud information.

14 in total

1. Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

Authors: B M Zeis; R Anderson; J F O'Sullivan
Journal: Antimicrob Agents Chemother Date: 1987-05 Impact factor: 5.191

2. Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

Authors: Sandeep Tyagi; Nicole C Ammerman; Si-Yang Li; John Adamson; Paul J Converse; Rosemary V Swanson; Deepak V Almeida; Jacques H Grosset
Journal: Proc Natl Acad Sci U S A Date: 2015-01-05 Impact factor: 11.205

3. Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.

Authors: Rosemary V Swanson; John Adamson; Chivonne Moodley; Bongani Ngcobo; Nicole C Ammerman; Afton Dorasamy; Sashen Moodley; Zinhle Mgaga; Asa Tapley; Linda A Bester; Sanil Singh; Jacques H Grosset; Deepak V Almeida
Journal: Antimicrob Agents Chemother Date: 2015-03-09 Impact factor: 5.191

8. Identification of crystals of the rimino-phenazine compound B663 (Lamprene: clofazimine) in mouse spleen macrophages by thin layer chromatography and mass spectrum analysis.

Authors: R T Aplin; A C McDougall
Journal: Experientia Date: 1975-04-15

Review 9. Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes.

Authors: Caoimhe Egan; Elaine S Jaffe
Journal: Semin Diagn Pathol Date: 2017-11-03 Impact factor: 3.464

10. Macrophages sequester clofazimine in an intracellular liquid crystal-like supramolecular organization.

Authors: Jason Baik; Gus R Rosania
Journal: PLoS One Date: 2012-10-11 Impact factor: 3.240

The antileprosy agent B.663 (Clofazimine) and the reticuloendothelial system.

1. Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

2. Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

3. Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.

4. Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.

5. Clofazimine Reduces the Survival of Salmonella enterica in Macrophages and Mice.

6. Molecular imaging of intracellular drug-membrane aggregate formation.

7. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.

8. Identification of crystals of the rimino-phenazine compound B663 (Lamprene: clofazimine) in mouse spleen macrophages by thin layer chromatography and mass spectrum analysis.

Review 9. Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes.

10. Macrophages sequester clofazimine in an intracellular liquid crystal-like supramolecular organization.